3-(TRIFLUOROMETHYL)-6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDINE HCL, 97.0%, 25mg

3-Methylbut-2-en-1-yl acetate, 95.0%, 500g

5',5''-Bis(4-formylphenyl)-2',2'',4',4'',6',6''-hexamethyl-[1,1':3',1'':3'',1'''-quaterphenyl]-4,4'''-dicarbaldehyde, 98%, 1g

2-(Dimethylamino)-2-(4-methylbenzyl)-1-(4-morpholinophenyl)butan-1-one, >95.0%(HPLC)(qNMR), 100g

4-Pyridinemethanol, 97.0%, 10g

4-Bromo-5-chloro-2-methylpyridinehydrobromide, 98%, 100mg

(1R*,4R*)-N1-(Pyridin-4-ylmethyl)cyclohexane-1,4-diamine hydrochloride, 1g

Colonne capillaire GC ROTI®Cap-1, 25 m, 0,32 mm, 5,00 µm, 1 pièce(s)

ethyl (2Z)-2-chloro-2-[2-(5-chloro-2-methoxyphenyl)hydrazin-1-ylidene]acetate, 95.0%, 1g

Nickel(II) 2,4-pentanedionate hydraté 98+% 250 g

3-ISOPROPYLTHIOPHENE-2-CARBOXYLIC ACID, 95%, 5g

Silver Bis(trifluoromethanesulfonyl)imide>98.0%(T)5g

3-(3-Methoxyphenyl)-4-phenyl-1,2,4-triazoline-5-thione, 95.0%, 5g